4,944,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) DISC MEDICINE, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • June 14th, 2024 • Disc Medicine, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 14th, 2024 Company Industry Jurisdiction
●] Shares ASTERA LABS, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • March 8th, 2024 • Astera Labs, Inc. • Semiconductors & related devices • New York
Contract Type FiledMarch 8th, 2024 Company Industry Jurisdiction
UNDERWRITING AGREEMENTUnderwriting Agreement • November 13th, 2023 • Spirit AeroSystems Holdings, Inc. • Aircraft parts & auxiliary equipment, nec • New York
Contract Type FiledNovember 13th, 2023 Company Industry JurisdictionThe undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Spirit AeroSystems Holdings, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including Morgan Stanley (the “Underwriters”), of 9,090,909 shares (the “Shares”) of Class A common stock, par value $0.01 per share, of the Company (the “Common Stock”).
14,300,000 Shares ALPHATEC HOLDINGS, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT October 24, 2023Underwriting Agreement • October 27th, 2023 • Alphatec Holdings, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledOctober 27th, 2023 Company Industry Jurisdiction
19,728,189 Shares CEREVEL THERAPEUTICS HOLDINGS, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • October 12th, 2023 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 12th, 2023 Company Industry JurisdictionCerevel Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom Goldman Sachs & Co. LLC (“Goldman”) is acting as representative (the “Representative”), 19,728,189 shares of its common stock, par value $0.0001 per share set forth in Schedule II hereto (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 2,959,228 shares of its common stock, par value $0.0001 per share set forth in Schedule II hereto (the “Additional Shares”) if and to the extent that the Representative shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, par value $0.0001 per share, of the Comp
45,000,000 OF SHARES OF Vicarious Surgical Inc. Class A common stock, par value $0.0001 per share UNDERWRITING AGREEMENTUnderwriting Agreement • August 4th, 2023 • Vicarious Surgical Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledAugust 4th, 2023 Company Industry JurisdictionThe undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) and Cowen and Company, LLC (“TD Cowen” and together with Morgan Stanley, the “Representatives”) propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Vicarious Surgical Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters named therein, including the Representatives (the “Underwriters”), of $45,000,000 of shares (the “Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”).
2,727,273 Shares IMMUNEERING CORPORATION CLASS A COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • April 19th, 2023 • Immuneering Corp • Pharmaceutical preparations • New York
Contract Type FiledApril 19th, 2023 Company Industry Jurisdiction
13,750,000 Shares INSMED INCORPORATED Common Stock, Par Value $0.01 Per Share UNDERWRITING AGREEMENTUnderwriting Agreement • October 20th, 2022 • INSMED Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 20th, 2022 Company Industry Jurisdiction
l] Shares BIOHAVEN LTD. COMMON SHARES, WITHOUT PAR VALUE FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • October 18th, 2022 • Biohaven Ltd. • Pharmaceutical preparations • New York
Contract Type FiledOctober 18th, 2022 Company Industry Jurisdiction
7,250,000 Shares CEREVEL THERAPEUTICS HOLDINGS, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • August 12th, 2022 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 12th, 2022 Company Industry JurisdictionCerevel Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom each of Morgan Stanley & Co. LLC (“Morgan Stanley”), Goldman Sachs & Co. LLC (“Goldman”), Jefferies LLC (“Jefferies”) and Evercore Group L.L.C. (“Evercore”) is acting as representative (each of Morgan Stanley, Goldman, Jefferies and Evercore, a “Representative” and collectively, the “Representatives”), 7,250,000 shares of its common stock, par value $0.0001 per share set forth in Schedule II hereto (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 1,087,500 shares of its common stock, par value $0.0001 per share set forth in Schedule II hereto (the “Additional Shares”) if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock g
●] Shares REV RENEWABLES, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • March 22nd, 2022 • REV Renewables, Inc. • Electric services • New York
Contract Type FiledMarch 22nd, 2022 Company Industry Jurisdiction
l ] Shares USERTESTING, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 8th, 2021 • UserTesting, Inc. • Services-prepackaged software • New York
Contract Type FiledNovember 8th, 2021 Company Industry Jurisdiction
7,000,000 Shares AIRSCULPT TECHNOLOGIES, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT October 28, 2021Underwriting Agreement • November 2nd, 2021 • Airsculpt Technologies, Inc. • Services-offices & clinics of doctors of medicine • New York
Contract Type FiledNovember 2nd, 2021 Company Industry JurisdictionThe undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”), Piper Sandler & Co., and SVB Leerink LLC (together, the “Representatives”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with AirSculpt Technologies, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including the Representatives (the “Underwriters”), of 7,000,000 shares (the “Shares”) of the common stock, par value $0.001 per share of the Company (the “Common Stock”).
•] Shares GLOBALFOUNDRIES Inc. ORDINARY SHARES, PAR VALUE $0.02 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 26th, 2021 • GLOBALFOUNDRIES Inc. • Semiconductors & related devices • New York
Contract Type FiledOctober 26th, 2021 Company Industry Jurisdiction
l ] Shares ALLBIRDS, INC. CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 25th, 2021 • Allbirds, Inc. • Apparel & other finishd prods of fabrics & similar matl • New York
Contract Type FiledOctober 25th, 2021 Company Industry JurisdictionAllbirds, Inc., a Delaware public benefit corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule II hereto (the “Underwriters”), and certain shareholders of the Company (the “Selling Shareholders”) named in Schedule I hereto severally propose to sell to the several Underwriters, an aggregate of [ l ] shares of the Class A common stock, par value $0.0001 per share, of the Company (the “Firm Shares”), of which [ l ] shares are to be issued and sold by the Company and [ l ] shares are to be sold by the Selling Shareholders, each Selling Shareholder selling the amount set forth opposite such Selling Shareholder’s name in Schedule I hereto.
Shares P10, INC. CLASS A COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • October 12th, 2021 • P10, Inc. • Investment advice • New York
Contract Type FiledOctober 12th, 2021 Company Industry Jurisdiction
•] Shares of Common Stock Life Time Group Holdings, Inc. Shares of Common Stock (par value $0.01 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • September 29th, 2021 • Life Time Group Holdings, Inc. • Services-membership sports & recreation clubs • New York
Contract Type FiledSeptember 29th, 2021 Company Industry Jurisdiction
•] Shares of Common Stock Life Time Group Holdings, Inc. Shares of Common Stock (par value $0.01 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • September 13th, 2021 • Life Time Group Holdings, Inc. • Services-membership sports & recreation clubs • New York
Contract Type FiledSeptember 13th, 2021 Company Industry Jurisdiction
Traeger, Inc. [•] SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • July 21st, 2021 • TGPX Holdings I LLC • Household appliances • New York
Contract Type FiledJuly 21st, 2021 Company Industry Jurisdiction
•] Shares CYTEK BIOSCIENCES, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • July 19th, 2021 • Cytek BioSciences, Inc. • Laboratory analytical instruments • New York
Contract Type FiledJuly 19th, 2021 Company Industry Jurisdiction
Shares BRIDGE INVESTMENT GROUP HOLDINGS INC. Class A Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 2nd, 2021 • Bridge Investment Group Holdings Inc. • Investment advice • New York
Contract Type FiledJuly 2nd, 2021 Company Industry Jurisdiction
•] Shares CONFLUENT, INC. CLASS A COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 16th, 2021 • Confluent, Inc. • Services-prepackaged software • New York
Contract Type FiledJune 16th, 2021 Company Industry Jurisdiction
●] Shares DOXIMITY, INC. CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 15th, 2021 • Doximity, Inc. • Services-computer programming services • New York
Contract Type FiledJune 15th, 2021 Company Industry JurisdictionMorgan Stanley & Co. LLC Goldman Sachs & Co. LLC J.P. Morgan Securities LLC c/o Morgan Stanley & Co. LLC 1585 Broadway New York, NY 10036 c/o Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, NY 10179
•] Shares WALKME LTD. ORDINARY SHARES, NO PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 14th, 2021 • WalkMe Ltd. • Services-prepackaged software • New York
Contract Type FiledJune 14th, 2021 Company Industry Jurisdiction
●] Shares Zeta Global Holdings Corp. Class A Common Stock, Par Value $.001 Per Share Underwriting AgreementUnderwriting Agreement • May 10th, 2021 • Zeta Global Holdings Corp. • Services-prepackaged software • New York
Contract Type FiledMay 10th, 2021 Company Industry JurisdictionThis letter is being delivered to Morgan Stanley & Co. LLC acting as representative (the “Representative”) in connection with the offering by Zeta Global Holdings Corp. (the “Company”) of [●] shares of Class A common stock, $.001 par value (the “Common Stock”), of the Company and the lock-up agreement dated [●], 2021 (the “Lock-up Agreement”), executed by you in connection with such offering, and your request for a [waiver/release] dated [●], 2021, with respect to [●] shares of Common Stock (the “Shares”).
] Shares TScan Therapeutics, Inc. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • April 30th, 2021 • TScan Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 30th, 2021 Company Industry Jurisdiction
5,000,000 Shares Rhythm Pharmaceuticals, Inc. Common Stock ($0.001 par value) UNDERWRITING AGREEMENTUnderwriting Agreement • February 5th, 2021 • Rhythm Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 5th, 2021 Company Industry JurisdictionRhythm Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, 5,000,000 shares of its common stock, $0.001 par value per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 750,000 shares of its common stock, $0.001 par value per share (the “Additional Shares”), if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, $0.001 par value per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to a
4,260,000 Shares REGENXBIO INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT January 7, 2021Underwriting Agreement • January 8th, 2021 • REGENXBIO Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 8th, 2021 Company Industry Jurisdiction
] Shares Sigilon Therapeutics, Inc. Common Stock, par value $0.001 UNDERWRITING AGREEMENTUnderwriting Agreement • November 30th, 2020 • Sigilon Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 30th, 2020 Company Industry JurisdictionThe undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) and Jefferies LLC (together with Morgan Stanley, the “Representatives”) propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Sigilon Therapeutics, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including the Representatives (the “Underwriters”), of shares (the “Shares”) of the common stock, par value $0.001 per share, of the Company (the “Common Stock”).
●] Shares BIGCOMMERCE HOLDINGS, INC. SERIES 1 COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 10th, 2020 • BigCommerce Holdings, Inc. • Services-prepackaged software • New York
Contract Type FiledNovember 10th, 2020 Company Industry Jurisdiction
11,428,570 Shares ALPHATEC HOLDINGS, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT October 13, 2020Underwriting Agreement • October 16th, 2020 • Alphatec Holdings, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledOctober 16th, 2020 Company Industry Jurisdiction
6,578,947 Shares PERSONALIS, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • August 12th, 2020 • Personalis, Inc. • Services-medical laboratories • New York
Contract Type FiledAugust 12th, 2020 Company Industry Jurisdiction
2U, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • August 10th, 2020 • 2U, Inc. • Services-prepackaged software • New York
Contract Type FiledAugust 10th, 2020 Company Industry JurisdictionThe undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with 2U, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters named in Schedule II to the Underwriting Agreement (the “Underwriters”), of shares (the “Shares”) of the common stock, $0.001 par value per share, of the Company (the “Common Stock”).
●] Shares BIGCOMMERCE HOLDINGS, INC. SERIES 1 COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • August 3rd, 2020 • BigCommerce Holdings, Inc. • Services-prepackaged software • New York
Contract Type FiledAugust 3rd, 2020 Company Industry Jurisdiction
●] Shares SELECTQUOTE, INC. COMMON STOCK ($0.01 PAR VALUE PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • May 19th, 2020 • SelectQuote, Inc. • Insurance agents, brokers & service • New York
Contract Type FiledMay 19th, 2020 Company Industry Jurisdiction